Ganglioside GM2

Ganglioside GM2 is a lipid of Sphingolipids (SP) class. Ganglioside gm2 is associated with abnormalities such as Sensory neuropathy, Neuropathy, Autoimmune Diseases, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating and Neuromuscular Diseases. The involved functions are known as Pressure- physical agent, Cytolysis, Inflammation, Complement-Dependent Cytotoxicity and conjugation. Ganglioside gm2 often locates in Membrane, Entire nervous system, Cell surface, Biopsy sample and Lipid Bilayers. The associated genes with Ganglioside GM2 are anti-IgM, Polypeptides, Transgenes, Alleles and Homologous Gene. The related lipids are Ganglioside GA2, QS 21, sulfate-3-glucuronyl paragloboside, Lipopolysaccharides and IV(4)-galactosyl-N-acetylganglioside GD1a. The related experimental models are Disease model.

References related to genes published in Others

PMID	Journal	Published Date	Author	Title
11358851	Cancer Res.	2001	Yoshida S et al.	Ganglioside G(D2) in small cell lung cancer cell lines: enhancement of cell proliferation and mediation of apoptosis.
15993494	J. Neuroimmunol.	2005	Moran AP et al.	Antibodies induced by ganglioside-mimicking Campylobacter jejuni lipooligosaccharides recognise epitopes at the nodes of Ranvier.
26175473	J. Lipid Res.	2015	Anheuser S et al.	Membrane lipids regulate ganglioside GM2 catabolism and GM2 activator protein activity.
25873306	ASN Neuro		Rockwell HE et al.	AAV-mediated gene delivery in a feline model of Sandhoff disease corrects lysosomal storage in the central nervous system.
25717099	Sci Transl Med	2015	Vite CH et al.	Intracisternal cyclodextrin prevents cerebellar dysfunction and Purkinje cell death in feline Niemann-Pick type C1 disease.
21487393	Mol. Ther.	2011	Matsuoka K et al.	Therapeutic potential of intracerebroventricular replacement of modified human β-hexosaminidase B for GM2 gangliosidosis.
20187655	ACS Chem. Biol.	2010	Ho CW et al.	Development of GlcNAc-inspired iminocyclitiols as potent and selective N-acetyl-beta-hexosaminidase inhibitors.
19559406
18241673	Clin. Biochem.	2008	Gu J et al.	Simultaneous quantification of GM1 and GM2 gangliosides by isotope dilution tandem mass spectrometry.
17915254	J. Neurol. Sci.	2008	Nobile-Orazio E et al.	How useful are anti-neural IgM antibodies in the diagnosis of chronic immune-mediated neuropathies?
17253773	Biochemistry	2007	Martinez Z et al.	GM1 specifically interacts with alpha-synuclein and inhibits fibrillation.
17198760	J. Feline Med. Surg.	2007	Hasegawa D et al.	Clinical and molecular analysis of GM2 gangliosidosis in two apparent littermate kittens of the Japanese domestic cat.
16962990	Arch. Biochem. Biophys.	2006	Duan J et al.	Ganglioside GM2 modulates the erythrocyte Ca2+-ATPase through its binding to the calmodulin-binding domain and its 'receptor'.
16707183	J. Biotechnol.	2006	Thiesen PH et al.	Glycolipids from a colloid chemical point of view.
16620986	Mol. Immunol.	2007	López-Requena A et al.	Gangliosides, Ab1 and Ab2 antibodies II. Light versus heavy chain: An idiotype-anti-idiotype case study.
16478472	FEBS J.	2006	Wendeler M et al.	The enzyme-binding region of human GM2-activator protein.
12705795	Intern. Med.	2003	Mizutani K et al.	Amyotrophic lateral sclerosis with IgM antibody against gangliosides GM2 and GD2.
11578853	Brain Dev.	2001	Taniguchi M et al.	Sites and temporal changes of gangliosides GM1/GM2 storage in the Niemann-Pick disease type C mouse brain.
11064828	Clin Rev Allergy Immunol	2000	Portoukalian J	Immunogenicity of glycolipids.
10704706	Lung Cancer	2000	Brezicka T et al.	Reactivity of monoclonal antibodies with ganglioside antigens in human small cell lung cancer tissues.
10571007	Biochim. Biophys. Acta	1999	Mahuran DJ	Biochemical consequences of mutations causing the GM2 gangliosidoses.
10529115	Microbiol. Immunol.	1999	Okada N et al.	Human IgM monoclonal antibody to ganglioside GM2 and complement suppress virus propagation in ex vivo cultures of lymphocytes from HIV-1 infected patients.
10073593	J. Am. Soc. Nephrol.	1999	Mundel TM et al.	Ganglioside GM2-activator protein and vesicular transport in collecting duct intercalated cells.
9972876	Neurochem. Res.	1999	Usuki S et al.	GM2 promotes ciliary neurotrophic factor-dependent rescue of immortalized motor neuron-like cell (NSC-34).
9728970	J. Neurol. Neurosurg. Psychiatry	1998	Tsukaguchi M et al.	IgM anti-GM2 antibody in a patient with Guillain-Barré syndrome subsequent to cytomegalovirus hepatitis cross reacts with N-acetylgalactosaminyl GD1a.
9668352	Ann. N. Y. Acad. Sci.	1998	Walkley SU et al.	GM2 ganglioside as a regulator of pyramidal neuron dendritogenesis.
9572057	Mol Med Today	1998	Chavany C and Jendoubi M	Biology and potential strategies for the treatment of GM2 gangliosidoses.
9435988	Clin. Chim. Acta	1997	Sandhoff K and Kolter T	Biochemistry of glycosphingolipid degradation.
8544979	Neuroscience	1995	Walkley SU	Pyramidal neurons with ectopic dendrites in storage diseases exhibit increased GM2 ganglioside immunoreactivity.
1291049	Carbohydr. Res.	1992	Schaeper RJ et al.	In vitro biosynthesis of GbOse4Cer (globoside) and GM2 ganglioside by the (1-->3) and (1-->4)-N-acetyl beta-D-galactosaminyltransferases from embryonic chicken brain. Solubilization, purification, and characterization of the transferases.
2977954	Br J Psychiatry	1988	Lichtenberg P et al.	Post-partum psychosis in adult GM2 gangliosidosis. A case report.